Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Phldb1em1flox/Cya
Common Name:
Phldb1-flox
Product ID:
S-CKO-18343
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Phldb1-flox
Strain ID
CKOCMP-102693-Phldb1-B6J-VB
Gene Name
Phldb1
Product ID
S-CKO-18343
Gene Alias
D330037A14Rik; Ll5a; Ll5alpha
Background
C57BL/6JCya
NCBI ID
102693
Modification
Conditional knockout
Chromosome
9
Phenotype
MGI:2143230
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Phldb1em1flox/Cya mice (Catalog S-CKO-18343) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000034611
NCBI RefSeq
NM_153537.4
Target Region
Exon 6
Size of Effective Region
~2.2 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Phldb1, or pleckstrin homology-like domain family B member 1, is an insulin-responsive protein. It contains a pleckstrin homology domain that binds phosphatidylinositol, as well as a Forkhead-associated domain and coiled-coil regions. PHLDB1 plays a role in insulin-dependent Akt phosphorylation, enhancing Akt activation, deoxyglucose transport, and GLUT4 translocation in adipocytes [9].

Genetic variations in PHLDB1 are associated with various diseases. In a Korean population, the rs67307131 SNP in PHLDB1 was significantly associated with non-functional pituitary adenoma (NFPA) [1]. A meta-analysis showed that the rs498872 polymorphism in PHLDB1 was associated with an increased risk of glioma [2]. Biallelic frameshift variants in PHLDB1 were identified in patients with a novel, mild-type, autosomal recessive osteogenesis imperfecta with regressive spondylometaphyseal changes [3]. In Chinese patients, the rs7389T/G polymorphism in PHLDB1 was related to systemic lupus erythematosus (SLE) susceptibility, with the G allele related to an increased level of TNF-α [4]. In the Chinese Han population, the rs17748 SNP in PHLDB1 was associated with breast cancer risk [5]. The rs7389 G/T genotype in PHLDB1 was associated with a higher IgA nephropathy risk in females [6]. In the Chinese Han population, the variant TT genotype of PHLDB1 rs498872 decreased glioblastoma (GBM) risk in the recessive model, and in the Portuguese population, the GA genotype of rs498872 was associated with an increased risk of gliomas and glioblastomas [7,8].

In conclusion, PHLDB1 is crucial in insulin-related metabolic processes. The identification of its genetic polymorphisms associated with multiple diseases, such as NFPA, glioma, osteogenesis imperfecta, SLE, breast cancer, IgA nephropathy, and GBM, through genetic studies, provides insights into the role of PHLDB1 in disease susceptibility. These findings contribute to a better understanding of the molecular mechanisms underlying these diseases and may potentially guide future diagnostic and therapeutic strategies.

References:
1. Kim, Lyoung Hyo, Kim, Jeong-Hyun, Namgoong, Suhg, Chang, Jong Hee, Shin, Hyoung Doo. 2019. A PHLDB1 variant associated with the nonfunctional pituitary adenoma. In Journal of neuro-oncology, 142, 223-229. doi:10.1007/s11060-018-03082-y. https://pubmed.ncbi.nlm.nih.gov/30868356/
2. Gao, Xingchun, Mi, Yajing, Yan, Aili, Jiang, Fengliang, Gou, Xingchun. 2014. The PHLDB1 rs498872 (11q23.3) polymorphism and glioma risk: A meta-analysis. In Asia-Pacific journal of clinical oncology, 11, e13-21. doi:10.1111/ajco.12211. https://pubmed.ncbi.nlm.nih.gov/24935770/
3. Tuysuz, Beyhan, Uludag Alkaya, Dilek, Geyik, Filiz, Vural, Mehmet, Bilguvar, Kaya. 2022. Biallelic frameshift variants in PHLDB1 cause mild-type osteogenesis imperfecta with regressive spondylometaphyseal changes. In Journal of medical genetics, 60, 819-826. doi:10.1136/jmg-2022-108763. https://pubmed.ncbi.nlm.nih.gov/36543534/
4. Zhai, Jianzhao, Zhang, Ping, Zhang, Naidan, Luo, Yubin, Wu, Yongkang. 2022. Analysis of WDFY4 rs7097397 and PHLDB1 rs7389 polymorphisms in Chinese patients with systemic lupus erythematosus. In Clinical rheumatology, 41, 2035-2042. doi:10.1007/s10067-022-06103-4. https://pubmed.ncbi.nlm.nih.gov/35188604/
5. Wei, Ying, Wang, Xiaolin, Zhang, Zhe, Cao, Hongxin, Zhao, Xinhan. . Role of Polymorphisms of FAM13A, PHLDB1, and CYP24A1 in Breast Cancer Risk. In Current molecular medicine, 19, 579-588. doi:10.2174/1566524019666190619125109. https://pubmed.ncbi.nlm.nih.gov/31215377/
6. Feng, Yuan, Su, Yan, Ma, Chunyang, Li, Wenning, Wei, Jiali. 2019. 3'UTR variants of TNS3, PHLDB1, NTN4, and GNG2 genes are associated with IgA nephropathy risk in Chinese Han population. In International immunopharmacology, 71, 295-300. doi:10.1016/j.intimp.2019.03.041. https://pubmed.ncbi.nlm.nih.gov/30928649/
7. Yang, Bo, Heng, Liang, Du, Shuli, Lang, Hongjun, Li, Shanqu. 2015. Association between RTEL1, PHLDB1, and TREH Polymorphisms and Glioblastoma Risk: A Case-Control Study. In Medical science monitor : international medical journal of experimental and clinical research, 21, 1983-8. doi:10.12659/MSM.893723. https://pubmed.ncbi.nlm.nih.gov/26156397/
8. Viana-Pereira, Marta, Moreno, Daniel Antunes, Linhares, Paulo, Vaz, Rui, Reis, Rui Manuel. 2019. Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients. In Molecular biology reports, 47, 877-886. doi:10.1007/s11033-019-05178-8. https://pubmed.ncbi.nlm.nih.gov/31721021/
9. Zhou, Qiong L, Jiang, Zhen Y, Mabardy, Allan S, Chawla, Anil, Czech, Michael P. 2010. A novel pleckstrin homology domain-containing protein enhances insulin-stimulated Akt phosphorylation and GLUT4 translocation in adipocytes. In The Journal of biological chemistry, 285, 27581-9. doi:10.1074/jbc.M110.146886. https://pubmed.ncbi.nlm.nih.gov/20587420/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest